BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2322617)

  • 1. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.
    Siek GC; Katz LS; Fishman EB; Korosi TS; Marquis JK
    Biol Psychiatry; 1990 Mar; 27(6):573-80. PubMed ID: 2322617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type.
    Fishman EB; Siek GC; MacCallum RD; Bird ED; Volicer L; Marquis JK
    Ann Neurol; 1986 Mar; 19(3):246-52. PubMed ID: 3963769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
    Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
    J Neurochem; 1986 Jul; 47(1):263-77. PubMed ID: 3711902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease.
    Schegg KM; Harrington LS; Neilsen S; Zweig RM; Peacock JH
    Neurobiol Aging; 1992; 13(6):697-704. PubMed ID: 1491735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.
    Schegg KM; Nielsen S; Zweig RM; Peacock JH
    Prog Clin Biol Res; 1989; 317():437-52. PubMed ID: 2602428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of acetylcholinesterase activity closely associated with amyloid beta/A4 protein is not correlated with acetylcholinesterase-positive fiber density in amygdala of Alzheimer's disease.
    Nakamura S; Takemura M; Suenaga T; Akiguchi I; Kimura J; Yasuhara O; Kimura T; Kitaguchi N
    Acta Neuropathol; 1992; 84(4):425-32. PubMed ID: 1441923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor.
    Mimori Y; Nakamura S; Yukawa M
    Behav Brain Res; 1997 Feb; 83(1-2):25-30. PubMed ID: 9062656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease.
    Hyman BT; Kromer LJ; Van Hoesen GW
    Ann Neurol; 1987 Mar; 21(3):259-67. PubMed ID: 3606033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T; Bigl V; Tennstedt A; Arendt A
    Neurosci Lett; 1984 Jul; 48(1):81-5. PubMed ID: 6472737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization.
    Nakamura S; Kawashima S; Nakano S; Tsuji T; Araki W
    J Neural Transm Suppl; 1990; 30():13-23. PubMed ID: 2391513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
    Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in membrane-bound and soluble molecular forms of acetylcholinesterase in mouse hippocampus after cholinergic denervation.
    Schegg KM; Gillespie RP; Prym U; Peacock JH
    Neurosci Lett; 1990 Oct; 118(2):197-200. PubMed ID: 2274269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic pathology in Alzheimer's disease.
    Saper CB; German DC
    Neurosci Lett; 1987 Mar; 74(3):364-70. PubMed ID: 2436113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential inhibition of acetylcholinesterase molecular forms in rat brain.
    Ogane N; Giacobini E; Messamore E
    Neurochem Res; 1992 May; 17(5):489-95. PubMed ID: 1528356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z
    Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size and charge isomers of acetylcholinesterase in the cerebral cortex of young and aged rats.
    Bisso GM; Briancesco R; Michalek H
    Neurochem Res; 1991 May; 16(5):571-5. PubMed ID: 1754033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of molecular isoforms of acetylcholinesterase in learning and memory functions.
    Das A; Dikshit M; Nath C
    Pharmacol Biochem Behav; 2005 May; 81(1):89-99. PubMed ID: 15882896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limbic system in Alzheimer's disease. A neuropathologic investigation.
    Hopper MW; Vogel FS
    Am J Pathol; 1976 Oct; 85(1):1-20. PubMed ID: 135514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.